P roton pump inhibitor (PPI)-refractory gastroesophageal reflux disease (GERD) is a pressing clinical problem constituting around 30% of patients with GERD. 1 In patients with GERD, 40%-49% complain of belching as a predominant symptom. 2, 3 Previously, patients with excessive belching were thought to swallow air frequently or in large volumes 4 resulting in air venting from the stomach, known as gastric belching (GB). Recently, it has been shown that supragastric belching (SGB) is the predominant type of belching in patients with GERD with excessive belching. 3, 5, 6 The underlying mechanism of SGB is involuntary diaphragmatic contraction resulting in rapid influx of air into the esophagus, followed by rapid air expulsion. 7 It has been shown that SGB can exacerbate GERD symptoms by directly inducing reflux episodes. 3, 5, 6 PPIs are used widely in GERD treatment and have been used for belching, [8] [9] [10] [11] but do not directly address the pathophysiology of SGB.
A single pilot study 12 has shown diaphragmatic breathing (DB) to be useful in SGB treatment but did not address whether GERD symptoms improved. To our knowledge, no study has determined whether DB is useful in patients with GERD and belching. We hypothesize that DB reduces belching and reflux symptoms in PPI-refractory patients with GERD and excessive belching. Therefore, we aimed to determine if DB is efficacious in improving belching and GERD symptoms, and in turn, improve quality of life (QoL).
Materials and Methods

Patient Selection
The study started in April 2015 when consecutive patients attending the gastroenterology clinic in a tertiary hospital in Singapore were invited to join after fulfilling inclusion criteria. Inclusion of patients ended in October 2016 and follow-up of last patient ended in April 2017.
The study design was a wait-list controlled cohort study. We included adult patients (!18 years) with clinical or endoscopic diagnosis of GERD, according to Montreal definition 13 and Los Angeles grade greater than or equal to B esophagitis, respectively. Patients needed to have troublesome belching over the last 6 months, with a belching visual analog scale (VAS) score of !6. All patients had PPI-refractory GERD, defined as having troublesome GERD (heartburn and/or regurgitation) despite twice daily PPI therapy for 12 weeks. 1 Organic or metabolic diseases were excluded by routine biochemistry and upper gastrointestinal endoscopy. Other exclusion criteria included pregnancy, patients with extreme body mass index (<18 or >35), or surgery involving the gastrointestinal tract because these may alter anatomy and physiology of the esophagus and stomach.
Informed consent was obtained from each participant and protocol was approved by Singhealth Centralised Institutional Review Board before the start of study. Wait-list control subjects (WLC) were not aware of an active treatment arm being compared with but were told that their symptoms would be reviewed at the end of the wait-list period and receive treatment regardless of their symptoms.
Questionnaires
All patients were given questionnaires at baseline, at the end of treatment with DB exercises, and 4 months post-treatment, with WLC given an additional questionnaire after their wait-list period (Figure 1 ). Because there were no validated questionnaires on belching, we asked patients to quantify their belching severity over the last 1 week via a 100-mm VAS, along with questions on frequency, ability to control, and repetitive nature of belching. To assess frequency and severity of GERD, patients were given the Reflux Disease Questionnaire (RDQ), which was validated in evaluating treatment response in GERD.
14 The RDQ consists of heartburn, regurgitation, and dyspepsia domains and assigns a score for these domains based on frequency and severity. 15 We measured GERD-specific QoL via RefluxQual Short Form (RQS) 16 and general health-related QoL via the EuroQol VAS. 17 Anxiety and depression levels were assessed using the Hospital Anxiety and Depression Scale (HADS). 18 Severity of somatic symptoms were assessed using the Patient Health Questionnaire-15.
19
Our primary outcome measured was !50% reduction in belching VAS at the end of treatment. Our secondary outcomes included improvements in reflux symptoms via RDQ and health-related QoL scales via RQS and EuroQol VAS.
pH-Impedance Measurements
High-resolution esophageal manometry (Medtronic Inc, Shoreview, MN) was performed to identify the position of the lower esophageal sphincter (LES) and rule out significant esophageal dysmotility. A combined pH-impedance catheter (Sandhill Scientific, Highlands Ranch, CO) was then placed transnasally at 5 cm above the LES. All patients underwent these tests and results were analyzed manually by 2 operators (A.M.-L.O., Y.-T.W.), both blinded to patient characteristics and questionnaire outcomes. All drugs affecting acid suppression, gastrointestinal motility, or sensitivity were discontinued at least 1 week before.
Gastric belches ( Figure 2A ) and supragastric belches ( Figure 2B ) were defined as previously described. 20 Patients were labelled as having excessive SGB if they had >13 supragastric belches per 24 hours. 6 Severe SGB was defined as more than 124 episodes per 24 hours. 6 Belches were associated with reflux if reflux episodes occurred within 1 second of a belch (Figure 2A ). If a reflux episode was preceded by multiple belches, the belch with the closest temporal association to the reflux episode was considered. A belch was considered symptomatic if it occurred within a 1-minute time window preceding a patient-reported belch (Figure 2A ). If multiple belches occurred during this window, only the belch with the closest temporal association to the reported belch symptom was considered.
Patients were diagnosed as GERD if they had pathologic acid exposure (acid exposure time >4% or Demeester score >14). Reflux hypersensitivity was diagnosed if they had no pathologic acid exposure but positive symptom association to reflux episodes (Reflux Symptom Index >50% and/or Reflux Symptom Association Probability >95%). Functional heartburn was diagnosed if there was no pathologic acid exposure or positive symptom association. 
Diaphragmatic Breathing Exercises
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Diaphragmatic Breathing Improves Belching and GERD 409 DB protocol can be found in Supplementary Table 1 and Supplementary Video 1.
Statistical Analysis
The study was initially designed to compare efficacy of DB in GB versus SGB. However, early into the study, it was noted that most patients recruited had SGB and the study protocol was amended with the new aim to compare treatment outcomes of post-DB patients with WLC in all belching patients with GERD. Assuming a similar standard deviation from the Hemmink et al 12 study, our study had at least 90% power to detect a mean difference of 3.3 in belching VAS between WLC and post-DB using 15 patients each. Characterized by rise in impedance in distal rings initially and then moving proximally, reflective of retrograde gas movement. Arrows indicate direction of airflow. This belch is symptomatic, evident by patient-reported symptom marker. Impedance levels return to levels lower than baseline, suggestive of concomitant reflux episode, acidic as pH <4. (B) Supragastric belch. Characterized by rise in impedance in proximal rings initially and then moving distally. This is followed by rapid return to baseline in distal leads first and then proximally, reflective of the quick gas expulsion. Arrows indicate direction of airflow.
All authors had access to the study data and reviewed and approved the final manuscript. Data are presented as mean AE standard deviation or median (interquartile range) after checking for normal distribution. We used paired and unpaired Student t test for parametric quantitative data from in-group and between-group comparisons, and Wilcoxon signed rank test for nonparametric quantitative data. Fisher exact test was used to compare categorical variables. Differences were considered significant when P was < .05.
Results
Patient Characteristics
Of 64 patients fulfilling the inclusion criteria, 36 patients were enrolled and completed the DB exercise training (25 women; 32 Chinese; mean age, 45.5 AE 12.7), with 27 patients excluded because of unwillingness to participate and 1 patient diagnosed with achalasia ( Figure 1 ). At baseline, patients had mean belching VAS of 7.4 AE 1.3 and mean RDQ score of 18.1 AE 14.0. HADS anxiety and depression scores were 8.9 AE 4.2 and 5.3 AE 3.1, respectively. An initial 15 patients underwent DB exercises immediately on enrolment (treatment group), whereas the subsequent 21 were WLC. These groups did not differ in demographics, symptom severity, psychiatric comorbidities, Patient Health Questionnaire-15, and QoL scores (Table 1 ). Adherence to DB exercise training was achieved in 33 of 36 (91.7%).
pH-Impedance Analyses
A total of 5 of 36 (13.9%) patients had GERD, 24 of 36 (66.7%) had reflux hypersensitivity, and 7 of 36 (14.9%) had functional heartburn. Thirty-two patients had excessive SGB, of which 5 patients had severe SGB. 6 Median number of belches per 24 hours was 46 (32-80), and 20% of supragastric belches were symptomatic, whereas 2% of gastric belches were symptomatic. A total of 44% of all reflux episodes detected were associated with a belch (Supplementary Table 2 ).
Primary Outcome
A total of 9 of 15 (60%) in treatment group reduced belching VAS by !50% post-DB, whereas 0% of WLC achieved this primary outcome after their wait list period (P < .001). A total of 14 of 15 (93.3%) in treatment group achieved some reduction in belching VAS, compared with 7 of 21 (33.3%) in WLC (P < .001). Mean belching VAS of treatment group was significantly reduced from 7.1 AE 1.5 to 3.5 AE 2.0 compared with WLC, 7.6 AE 1.1 to 7.4 AE 1.3 ( Figure 3A and B) . A total of 80% in treatment group had reduction in belching frequency compared with 19% in WLC (P ¼ .001), whereas 40% in treatment group improved belch control compared with 4.8% in WLC (P ¼ .01) ( Table 2 ).
Secondary Outcomes
RDQ scores was significantly improved in treatment group patients compared with WLC (12.2 AE 11.7 vs 3.1 AE 7.9; P ¼ .01). All 3 domains of RDQ (heartburn, dyspepsia, regurgitation) showed improvement in post-DB patients, but only changes in regurgitation domains had statistical significance (5.1 AE 4.4 vs 0.2 AE 3.5; P ¼ .001) ( Table 2 ). RQS scores (15.4 AE 15.1 vs 5.1 AE 12.2; P ¼ .04) and EuroQol VAS (15.7 AE 10.7 vs -2.4 AE 10.2; P < .001) improved significantly in treatment group compared with WLC. There were no differences in improvements of HADS scores between treatment group patients and WLC.
Follow up
All 21 WLC underwent DB eventually and improved their belching VAS, from 7.4 AE 1.3 to 4.8 AE 1.8 (P < .001). Nine of 21 WLC (42.9%) achieved the primary outcome of reducing belching VAS by !50% post-DB. Nineteen of 21 patients (90.5%) of WLC showed significant improvements in their belching frequency and 9 of 21 (42.9%) improved belch control post-DB (Supplementary Table 3 ). Overall, 20 of all 36 patients (55.6%) who underwent DB achieved the primary outcome.
We followed up 30 out of 36 all post-DB patients at 4 months post-treatment. All clinical outcomes (primary and secondary) remained significantly improved compared with baseline, but deteriorated from end of treatment (Figure 4) . A total of 27 of 30 (90.0%) were compliant to home exercises when asked during their follow-up visit. There were no differences in clinical outcomes between those compliant and those noncompliant to home exercises.
Treatment Response Based on Type of Belching
All 20 patients who achieved the primary outcome had excessive SGB, whereas none of the patients without excessive SGB achieved this (P ¼ .03). 78% of those with excessive SGB reduced belching frequency compared with 25% of those without excessive SGB (P ¼ .06), and also had greater improvement in RDQ (12.2 AE 12.1 vs 3.8 AE 4.0; P ¼ .18) and greater improvement in RQS (17.4 AE 13.6 vs 10.2 AE 20.0; P ¼ .35) compared with patients without excessive SGB, but these were not statistically significant.
No differences were found between responders and nonresponders with regards to gender, pH-impedance diagnoses, severity of SGB, HADS scores, or somatization scales (Supplementary Table 4 ).
Discussion
Our study showed that in a group of PPI-refractory patients with GERD, standardized DB exercise training significantly reduced belching severity and GERD symptoms, and improved patient QoL. These benefits were greater in patients with excessive SGB, and sustainable at 4 months post-treatment. Although belching is common in GERD, 3 little research has been done in this, and there are no studies looking at treatment strategies for these patients. Ours is the first such study examining the efficacy of DB exercises in patients with GERD and belching.
DB may improve belching through several mechanisms. Early case studies 21 had shown belching reduction in children with developmental disabilities by teaching a response incompatible with swallowing, such as biting on forefingers. Other case reports in adults 22, 23 have shown that eliminating subconscious repetitive swallowing via keeping the mouth open combined with teaching slow DB was effective in reducing belching. However, reducing air swallowing is unlikely to be the sole mechanism for improvement as other studies 20 have shown that patients with excessive belching did not exhibit excessive air swallows. Kessing et al 24 showed that most supragastric belches are initiated by creation of subatmospheric pressure in the thoracic cavity by movement of the diaphragm in the aboral direction. Because the diaphragm consists of striated muscle under voluntary contraction, patients theoretically can be taught how to control these contractions. However, most of our patients with improvement in belching were still not able to control their belch voluntarily, so perhaps it is a combination of both previously mentioned factors mediating the reduction of belching frequency.
It is likely that reduction in SGB frequency accounted for most symptom improvement. Our subgroup analysis showed that only patients with excessive SGB achieved the primary outcome, whereas those without excessive SGB did not do so. GB has a completely different mechanism involving transient LES relaxations triggered by proximal stomach distention, 7 and therefore these patients may not respond to DB exercises. There is also a second less common mechanism of SGB 24 that involves an increase in pharyngeal pressure causing air influx into the esophagus as the initiating mechanism. Perhaps some of our patients not responding to DB exercises either had mostly GB or had SGB associated with changes in pharyngeal pressure. We were not able to distinguish which SGB mechanisms were predominant in our patients because we did not perform prolonged post-prandial high-resolution esophageal manometry monitoring to evaluate the characteristics of belches, but this would be interesting to explore.
GERD symptoms significantly improved after undergoing DB exercises, and this is largely mediated by improvement in regurgitation reflected by the changes in RDQ domains. Regurgitation scores significantly improved from baseline but not heartburn and dyspepsia scores. Hemmink et al 3 showed that SGB can occur either at the onset or during a liquid reflux episode and our study further confirms the close relationship between GERD and SGB. In our patients, 44% of all reflux events were associated with a belch, and most of these were supragastric belches. It is likely these events were contributing to the patient's symptom burden. In our patients, supragastric belches were more likely to be symptomatic compared with gastric belches (20% vs 2%) and this was also shown by Kessing et al. 5 We postulate that DB exercises improved GERD symptoms via reducing SGB frequency, which then reduces the frequency of SGB-associated GERD symptoms, especially regurgitation. Although we did not repeat pH-impedance studies post-DB, it could be inferred that because patients reported reduced belching frequency in their post-treatment questionnaires, the number of reflux events were possibly reduced. Further studies looking at number of reflux episodes and acid exposure time pre-and post-DB exercise training would support this theory. There are, however, other possible mechanisms accounting for improvement in belching and GERD symptoms after DB. The importance of the crural diaphragm is recognized in maintaining the antireflux barrier at the LES, and abdominal breathing exercises have been shown to improve GERD symptoms independent of belching. 25 Because SGB can be a response from an unpleasant sensations, such as reflux episodes, 3 DB exercises could potentially improve the antireflux barrier by strengthening the tone at the crural diaphragm resulting in less frequent reflux episodes and hence, less SGB episodes. Another possible mechanism could be related to psychological factors, which have been shown to be important in the initiation and perpetuation of SGB. 26 DB exercises is a relaxation technique shown to reduce anxiety 27 and belching may be reduced by modulating attention via distraction, 26 so perhaps these exercises distracted the patient from belching, or had a relaxation effect to reduce their anxiety. Our patients had a mean HADS anxiety score of 8.9, reflecting a high prevalence of anxiety, but in our analysis, although there were significant reductions in both HADS anxiety and depression scores pretreatment and post-treatment, there were no differences between treatment group and WLC (Table 2) . Furthermore, it is not clear if improvements in symptoms led to improvements in mood, or if reductions in anxiety levels mediated the improvement in belching.
PPI-refractory GERD has many possible mechanisms, and there is a subgroup of patients whose reflux symptoms are precipitated by events such as SGB. We found that most of our patients did not have GERD on pHimpedance, but had been diagnosed as having GERD largely based on the Montreal Classification. Interestingly, our pH-impedance studies showed that 66.7% and 19.4% (Supplementary Table 2 ) had reflux hypersensitivity and functional heartburn, respectively, but subgroup analysis did not show any differences in treatment response between pH-impedance diagnoses, likely because of our small sample size (Supplementary Table 4 ). All 36 patients were on stable twice-daily dosing of PPI during the intervention, but only 10 of 36 (27.8%) of these patients were still on PPI post-DB. Because DB exercises are safe, unlike PPIs where there are concerns on long-term safety, 28 DB may be an attractive therapeutic option. However, based on our results, recommendations for using DB for GERD can only be made for those with excessive belching, especially SGB.
There are several limitations to our study. The study protocol was amended early in the study. Therefore, we could not randomize the allocation of patients to treatment and WLC groups, although we showed in Table 1 that groups were similar in demographics and baseline symptom severity. WLC studies may overestimate treatment effects 29 but we believed that our primary outcome of reducing belching VAS by !50% had been set at a high and clinically meaningful threshold to mitigate this. Regardless, we would still need to confirm our findings via a randomized controlled trial. We did not use Rome III criteria for belching disorders 4 but used inclusion criteria of troublesome belching for last 6 months with VAS !6. There was no available validated measure at the time of study, but we believe that belching VAS was clinically meaningful because it encompasses frequency, severity, and QoL, and furthermore was used in the study by Hemmink et al. 12 This likely excluded patients with mild belching and hence the results may not be generalizable to all belching patients. Our sample size was relatively small and hence underpowered to detect differences in subgroup analysis of responders, but despite these limitations, this is the largest study evaluating treatment in patients with belching and the first looking at treatment options in patients with GERD and belching.
In conclusion, we showed that a standardized DB exercise training protocol improves belching, GERD symptoms, and QoL in patients with PPI-refractory GERD and belching, especially those with excessive SGB. DB exercise training can be a useful adjunct to current pharmacologic options in treating these patients.
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